Structure via PubChem · Public domain (PubChem)
dextropropoxyphene
Sign in to saveAlso known as (+)-alpha-propoxyphene, Darvon®, propoxyphene, d-Propoxyphene, alpha-D-4-Dimethylamino-3-methyl-1,2-diphenyl-2-butanol-propionat, alpha-(+)-4-Dimethylamino-1,2-diphenyl-3-methyl-2-butanol propionate ester, Dextropropoxyphen, Destropropossifene
Dextropropoxyphene is an opioid analgesic patented in 1955 and manufactured by Eli Lilly and Company. It is an optical isomer of levopropoxyphene. It is intended to treat mild pain and also has antitussive (cough suppressant) and local anesthetic effects. The drug has been taken off the market in Europe and the United States due to concerns of fatal overdoses and heart arrhythmias. It is still available in Australia, albeit with restrictions after an application by its manufacturer to review its proposed banning. Its onset of analgesia (pain relief) is said to be 20–30 minutes and peak effects
Key facts
- Drug.Verifiedfields
- changed
- Drug.Watchedfields
- changed
- Drug.class
- Opioid
- Drug.verifiedrevid
- 460780758
- Drug.IUPAC_name
- (1S,2R)-1-benzyl-3-(dimethylamino)-2-methyl-1-phenylpropyl propionate
- Drug.image
- Dextropropoxyphene structure.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 200px
- Drug.image2
- Dextropropoxyphene3DanJ.gif
- Drug.image_class2
- bg-transparent
- Drug.width2
- 200px
- Drug.tradename
- Darvon, Darvocet
- Drug.MedlinePlus
- a682325
- Drug.licence_US
- Propoxyphene
- Drug.pregnancy_AU
- C
- Drug.legal_AU
- S4
- Drug.legal_BR
- A2
- Drug.legal_CA
- Schedule I
via Wikipedia infobox
Chemical data
- Formula
- C22H29NO2
- Molecular weight
- 339.5 g/mol
- IUPAC name
- [(2S,3R)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate
- SMILES
- CCC(=O)O[C@](CC1=CC=CC=C1)(C2=CC=CC=C2)[C@H](C)CN(C)C
- InChIKey
- XLMALTXPSGQGBX-GCJKJVERSA-N
- XLogP
- 4.2
- Polar surface area
- 29.5 Ų
- H-bond donors
- 0
- H-bond acceptors
- 3
- Formal charge
- 0
via PubChem
Research
1,965 papersvia PubMed
Wikidata facts
- Mass
- 339.219829
Show 6 more facts
- isomeric SMILES
- CCC(=O)O[C@@](CC1=CC=CC=C1)([C@H](C)CN(C)C)C2=CC=CC=C2
- chemical formula
- C₂₂H₂₉NO₂
- canonical SMILES
- CCC(=O)OC(CC1=CC=CC=C1)(C2=CC=CC=C2)C(C)CN(C)C
- NCI Thesaurus ID
- C61912
- World Health Organisation international non-proprietary name
- dextropropoxyphene
- Commons category
- Dextropropoxyphene
Sources (5)
via Wikidata · CC0
~17 min read
Article
25 sectionsContents
- Medical uses
- Analgesia
- Restless legs syndrome
- Available forms
- Contraindications
- Side effects
- Pharmacology
- Toxicity
- History
- Use in organic synthesis
- Society and culture
- Usage controversy and regulation
- Australia
- Canada
- European Union
- New Zealand
- India
- Sweden
- United Kingdom
- United States
- In media
- Use by right-to-die societies
- Drug testing
- See also
- References
Dextropropoxyphene is an opioid analgesic patented in 1955 and manufactured by Eli Lilly and Company. It is an optical isomer of levopropoxyphene. It is intended to treat mild pain and also has antitussive (cough suppressant) and local anesthetic effects. The drug has been taken off the market in Europe and the United States due to concerns of fatal overdoses and heart arrhythmias. It is still available in Australia, albeit with restrictions after an application by its manufacturer to review its proposed banning. Its onset of analgesia (pain relief) is said to be 20–30 minutes and peak effects are seen about 1.5–2.0 hours after oral administration.
Dextropropoxyphene is sometimes combined with paracetamol (acetaminophen). Trade names include Darvocet-N, Di-Gesic, and Darvon with APAP (for dextropropoxyphene and paracetamol). The British approved name (i.e. the generic name of the active ingredient) of the paracetamol/dextropropoxyphene preparation is co-proxamol (sold under a variety of brand names); however, it has been withdrawn since 2007, and is no longer available to new patients, with exceptions. The paracetamol combinations are known as Capadex or Di-Gesic in Australia, Lentogesic in South Africa, and Di-Antalvic in France (unlike co-proxamol, which is an approved name, these are all brand names).